These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7960760)

  • 1. [Allergic drug exanthema to heparin. Cutaneous reactions to high molecular and fractionated heparin].
    Greiner D; Schöfer H
    Hautarzt; 1994 Aug; 45(8):569-72. PubMed ID: 7960760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction.
    Bircher AJ; Flückiger R; Buchner SA
    Br J Dermatol; 1990 Oct; 123(4):507-14. PubMed ID: 2151304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probable cutaneous allergic response to subcutaneous heparin--a case report.
    Gupta S; Mishra P; Palaian S; Prabhu S; Bista D; Prabhu M
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Jun; 15(2):98-101. PubMed ID: 16998611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fondaparinux as an alternative therapy in heparin-induced delayed-type hypersensitivity skin lesions.
    O'Meara AC; Demarmels Biasiutti F; Heizmann M
    Thromb Haemost; 2007 Dec; 98(6):1389-91. PubMed ID: 18064346
    [No Abstract]   [Full Text] [Related]  

  • 5. Enoxaparin-induced generalized exanthem.
    Kim KH; Lynfield Y
    Cutis; 2003 Jul; 72(1):57-60. PubMed ID: 12889716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium nadroparin in the prevention of thromboembolic disease in elderly subjects. Study of tolerance].
    Forette B; Wolmark Y
    Presse Med; 1995 Mar; 24(12):567-71. PubMed ID: 7770402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual reaction to subcutaneous heparin.
    Tosti A; De Padova MP; Patrizi A; Minghetti G; Veronesi S
    Contact Dermatitis; 1985 Sep; 13(3):190. PubMed ID: 2932288
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed hypersensitivity reaction to subcutaneous heparin.
    Rivers JK; Gianoutsos MP
    Aust N Z J Surg; 1991 Nov; 61(11):865-8. PubMed ID: 1836326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R; Gall H; Peter RU
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin tests in patients with delayed and immediate hypersensitivity to heparins: A case series.
    Tramontana M; Hansel K; Bianchi L; Agostinelli D; Stingeni L
    Contact Dermatitis; 2019 Mar; 80(3):170-172. PubMed ID: 30450556
    [No Abstract]   [Full Text] [Related]  

  • 12. Generalized eczema induced by nadroparin.
    Estrada Rodriguez JL; Gozalo Reques F; Ortiz de Urbina J; Matilla B; Rodriguez Prieto MA; Gonzalez Moran NA
    J Investig Allergol Clin Immunol; 2003; 13(1):69-70. PubMed ID: 12861855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of 19 cases of allergy to heparins with positive skin testing].
    Phan C; Vial-Dupuy A; Autegarden JE; Amsler E; Gaouar H; Abuaf N; Pecquet C; Francès C; Soria A
    Ann Dermatol Venereol; 2014 Jan; 141(1):23-9. PubMed ID: 24461090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergy to heparin: a new in vitro diagnostic technique.
    Caballero MR; Fernández-Benítez M
    Allergol Immunopathol (Madr); 2003; 31(6):324-8. PubMed ID: 14670287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type IV hypersensitivity to subcutaneous heparin: a new case.
    Gonzalo Garijo MA; Revenga Arranz F
    J Investig Allergol Clin Immunol; 1996; 6(6):388-91. PubMed ID: 9015784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and efficacy of Heparin and Nadroparin compared to placebo in acute ischemic stroke - pilot study.
    Dluha J; Sivak S; Kurca E; Dusenka R; Kalmarova K; Turcanova Koprusakova M; Kantorova E; Nosal V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):543-548. PubMed ID: 27646496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergy to subcutaneous heparin.
    Young E
    Contact Dermatitis; 1988 Aug; 19(2):152-3. PubMed ID: 2972526
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of hospital cost of six days of treatment of deep venous thrombosis. Comparison of subcutaneous nadroparin and intravenous heparin in 40 patients].
    Lévesque H; Cailleux N; Vasse D; Legallicier B; Moore N; Borg JY; Hantute N; Thuillez C; Courtois H
    Therapie; 1994; 49(2):101-5. PubMed ID: 7817331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed hypersensitivity to low-molecular-weight heparin (LMWH) in pregnancy.
    Schapkaitz E; Jacobson BF
    S Afr Med J; 2007 Dec; 97(12):1255-7. PubMed ID: 18271118
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids.
    Boehncke WH; Weber L; Gall H
    Contact Dermatitis; 1996 Aug; 35(2):73-5. PubMed ID: 8917822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.